Brooks Laboratories
BROOKSNSE

Brooks Laboratories

₹49.812.35 (4.95%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
47.44
Today’s high
49.83
52 week low
36.30
52 week high
164.02
Open price
48.60
Previous close
47.46
Live volume
1,27,699
Lower circuit
47.32
Upper circuit
52.30

Fundamentals

Market Cap
₹142Cr
ROE
12.08%
P/E Ratio(TTM)
6.60
EPS(TTM)
7.33
P/B Ratio
1.23
Dividend Yield
0.00%
Industry P/E
34.27
Book Value
39.27
Debt to Equity
0.07
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
DEC '25
Revenue (Cr)
₹16.70
-29.95%
Profit (Cr)
₹5.50
-31.08%
-100102030
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Revenue growthValue
1Y (TTM)-19%
3Y CAGR-3%
Profit growthValue
1Y (TTM)+358%
3Y CAGR+25%

About

Brooks Laboratories Limited is a pharmaceutical manufacturing company, producing injectable products like penicillins and cephalosporins for global markets.;
CEO/MD
Dr. Durga Maity
Founded in
2002
NSE symbol
BROOKS

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
52.62%
Retail And Others
36.84%
Mutual Funds
9.90%
Other Domestic Institutions
0.48%
Foreign Institutions
0.17%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Innova CaptabINNOVACAP
₹871.85
+16.60 (1.94%)
L
    H
    4,968.5535.254.55
    ₹362.30
    -23.20 (6.02%)
    L
      H
      3,946.1882.4914.92
      ₹402.00
      -17.35 (4.14%)
      L
        H
        3,756.3841.915.15
        Orchid PharmaORCHPHARMA
        ₹708.65
        -11.40 (1.58%)
        L
          H
          3,589.90190.272.82
          2026
          6
          Feb
          Quarterly Result
          Release date
          2025
          14
          Nov
          Quarterly Result
          Release date
          13
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks